Fátima Gebauer
Group leader
CRG – Centre for Genomic Regulation
Pere Virgili Health Research Institute
Spain
Biography
Dr. Fátima Gebauer is affiliated to CRG – Centre for Genomic Regulation, Pere Virgili Health Research Institute. Dr. Fátima Gebauer is currently providing services as Group leader. Dr. Fátima Gebauer has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Fátima Gebauer contributions have acclaimed recognition from honourable subject experts around the world. Dr. Fátima Gebauer is actively associated with different societies and academies. Dr. Fátima Gebauer academic career is decorated with several reputed awards and funding. Dr. Fátima Gebauer research interests include Epigenetic Events in Cancer.
Research Interest
Regulation of Protein Synthesis in Eukaryotes
Publications
-
GEBAUER, FATIMA, HENTZE, MATTHIAS W.. IRES Unplugged. IRES unplugged. Science 351 228-228. 15/01/2016. F.I.:37.205
-
GEBAUER, FATIMA. Role Of The RNA Binding Protein UNR/CSDE1 In Cancer Progression. Role of the RNA binding protein UNR/CSDE1 in cancer progression. Cancer Res. 77 -. 01/03/2017. F.I.:9.122
-
MARTINEZ-USEROS, JAVIER, GEORGIEV-HRISTOV, TIHOMIR, JESUS FERNANDEZ-ACENERO, MARIA, BORRERO-PALACIOS, AUREA, INDACOCHEA, ALBERTO, GUERRERO, SANTIAGO, LI, WEIYAO, CEBRIAN, ARANCHA, GOMEZ DEL PULGAR, TERESA, PUIME-OTIN, ALBERTO, DEL PUERTO-NEVADO, LAURA, RODRIGUEZ-REMIREZ, MARIA, PEREZ, NURIA, CELDRAN, ANGEL, GEBAUER, FATIMA, GARCIA-FONCILLAS, JESUS. UNR/CDSE1 Expression As Prognosis Biomarker In Resectable Pancreatic Ductal Adenocarcinoma Patients: A Proof-Of-Concept. UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept. PLoS One 12 -. 01/08/2017. F.I.:2.806
